|
Re: great news: timelines for data readouts in new corporate presentation just released late yesterday
|
3
|
BIOASIS TECHNOLOGIES INC
|
Mar 24, 2021 11:07AM
|
|
BIO International 2018
|
3
|
Zenith Epigenetics
|
May 02, 2018 05:30PM
|
|
Re: RRR Calculation
|
3
|
Resverlogix Corp.
|
Mar 20, 2019 09:05PM
|
|
Re: Resverlogix Announces Successful Phase 1 Renal Trial Results...
|
3
|
Resverlogix Corp.
|
Nov 17, 2016 11:02AM
|
|
Reply from Sarah
|
3
|
Zenith Epigenetics
|
Dec 11, 2015 02:21PM
|
|
Re: MACE event rate
|
3
|
Resverlogix Corp.
|
Nov 03, 2018 11:21PM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 18, 2019 02:48PM
|
|
Re: No Threats?
|
3
|
BIOASIS TECHNOLOGIES INC
|
Aug 03, 2016 10:50AM
|
|
What we know about BoM so far
|
3
|
Resverlogix Corp.
|
Aug 29, 2015 08:27AM
|
|
Q4 2017 Events
|
3
|
Resverlogix Corp.
|
Oct 21, 2017 08:14AM
|
|
Re: The synergy of rosuvastatin (Crestor) with apabetalone
|
3
|
Resverlogix Corp.
|
Oct 06, 2019 09:20AM
|
|
Re: Link to the webcast
|
3
|
Resverlogix Corp.
|
Nov 18, 2019 09:02AM
|
|
Re: aberaterone
|
3
|
Zenith Epigenetics
|
Jun 24, 2018 04:00PM
|
|
5 of 8 Sites Now Recruiting for ZEN-3694/Enzalutamid... Trial
|
3
|
Zenith Epigenetics
|
Feb 23, 2017 03:18PM
|
|
Re: people whining about the whining
|
3
|
Resverlogix Corp.
|
Dec 23, 2020 04:09PM
|
|
Re: Comments on the AGM
|
3
|
Resverlogix Corp.
|
Nov 08, 2019 12:33PM
|
|
Crossing the blood-brain barrier: Bioasis Technologies lead the way with their xB3 technology platform
|
3
|
BIOASIS TECHNOLOGIES INC
|
Aug 22, 2018 02:19PM
|
|
Re: Patient Enrollment Modeling
|
3
|
Resverlogix Corp.
|
Dec 09, 2018 09:39AM
|
|
Zenith BIO-Europe
|
3
|
Zenith Epigenetics
|
Mar 27, 2019 11:01AM
|
|
Re: Resverlogix Special Meeting Jun 30 9am MDT
|
3
|
Resverlogix Corp.
|
Jun 30, 2015 04:36PM
|
